Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CODX

Co-Diagnostics Inc

May 22 • 04:00PM ET

5.07

+1.36 36.66 %

Healthcare • Medical Devices • USA • Nano • NASD

May 22, 8:31 PMEbola assay strategy announcement drives Co-Diagnostics 37% surge amid outbreak

Peers: INBS VNRX BCDA AEMD NDRA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-28.01	Insider Own	4.98%	Shs Outstand	3.60M	Perf Week	294.55%
Market Cap	18.26M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	3.42M	Perf Month	196.49%
Enterprise Value	12.06M	PEG	-	EPS next Q	-	Inst Own	1.44%	Short Float	2.77%	Perf Quarter	118.77%
Income	-48.50M	P/S	35.80	EPS this Y	-	Inst Trans	-6.52%	Short Ratio	0.02	Perf Half Y	-50.63%
Sales	0.51M	P/B	1.14	EPS next Y	-	ROA	-126.56%	Short Interest	0.09M	Perf YTD	0.24%
Book/sh	4.45	P/C	2.22	EPS next 5Y	-	ROE	-151.66%	52W High	46.50 -89.10%	Perf Year	-29.76%
Cash/sh	2.29	P/FCF	-	EPS past 3/5Y	-37.47% -	ROIC	-281.74%	52W Low	1.26 302.38%	Perf 3Y	-87.20%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-76.97% -64.54%	Gross Margin	-187.30%	Volatility	48.62% 23.31%	Perf 5Y	-98.00%
Dividend TTM	-	EV/Sales	23.65	EPS Y/Y TTM	18.03%	Oper. Margin	-6255.15%	ATR (14)	0.64	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.09	Sales Y/Y TTM	-9.46%	Profit Margin	-9438.49%	RSI (14)	81.08	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.28	EPS Q/Q	42.48%	SMA20	154.68%	Beta	1.52	Target Price	45.00
Payout	-	Debt/Eq	0.13	Sales Q/Q	190.30%	SMA50	167.49%	Rel Volume	1.95	Prev Close	3.71
Employees	115	LT Debt/Eq	0.07	Earnings	May 14 AMC	SMA200	-23.38%	Avg Volume	4.98M	Price	5.07
IPO	Jul 12, 2017	Option/Short	No / No	EPS/Sales Surpr.	- 14.87%	Trades		Volume	9,731,827	Change	36.66%

May-19-26 10:54PM	Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules (PR Newswire) +43.80% +21.32%
10:34AM	Co-Diagnostics Develops Ebola Assay Strategy Following WHO Emergency Alert (CODX) (InvestorsHub)
May-15-26 08:30AM	Co-Diagnostics, Inc. Q1 2026 Earnings Call Summary (Moby) -21.17%
01:02AM	Co-Diagnostics Inc (CODX) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial ... (GuruFocus.com)
May-14-26 04:01PM	Co-Diagnostics Reports First Quarter 2026 Financial Results (PR Newswire)
05:43AM	Loading…
May-11-26 05:43AM	CoMira concludes lease agreement for plant in Sudair Industrial City, Saudi Arabia (Medical Device Network) -24.90%
May-08-26 09:00AM	Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City (PR Newswire) +31.09%
Apr-16-26 09:00AM	Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. (PR Newswire)
Apr-14-26 09:00AM	Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany (PR Newswire)
Apr-09-26 09:00AM	Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah (PR Newswire)
Apr-02-26 09:00AM	Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City (PR Newswire)
Apr-01-26 08:30AM	Co-Diagnostics, Inc. Q4 2025 Earnings Call Summary (Moby) -12.90%
Mar-31-26 11:02PM	Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... (GuruFocus.com) +9.41%
04:01PM	Co-Diagnostics Reports Full Year 2025 Financial Results (PR Newswire)
Mar-25-26 08:00AM	Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization (PR Newswire) -13.22%
03:30PM	Loading…
Mar-20-26 03:30PM	Co-Diagnostics (CODX) Expands CoSara Distribution Territory Across South Asia (NewMediaWire)

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

ChairmanMr. Dwight H. Egan

PresidentMr. Richard David Abbott

CFO & Company SecretaryMr. Brian L. Brown CPA

Chief Operating OfficerMr. David Nielsen

Vice President of Finance & AccountingMr. Dan Bohrer CPA

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CODX

Co-Diagnostics Inc

Upgrade your Finviz experience